Skip to content
Home/Companies/Healthcare / Biotech/Borea Therapeutics
Borea Therapeutics

Borea Therapeutics

Healthcare / Biotech·Italy·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Borea Therapeutics?

Borea Therapeutics is currently owned by Sofinnova Partners through Sofinnova Telethon (2016 vintage), since 2021.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Telethon · 2016 · Life Sciences VC

Key facts

HQItaly
SectorHealthcare / Biotech
Websitewww.boreatherapeutics.com

More from Sofinnova Telethon

Other portfolio companies in the same fund.

nChroma (formerly Chroma Medicine)
nChroma (formerly Chroma Medicine)
Active
BiotechUS· 2022
Nephris
Nephris
Active
BiotechItaly· 2022
Alia Therapeutics
Alia Therapeutics
Active
BiotechItaly· 2021
AAVantgarde Bio
Active
BiotechItaly· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Borea Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Borea Therapeutics?

0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Borea Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue